Abstract:Highlights • CircRNA hsa_circ_0001402 inhibits VSMC proliferation and migration, while activating VSMC autophagy, thereby alleviating neointimal hyperplasia. • MiR-183-5p decreases FKBPL levels by targeting the coding sequence of FKBPL , promoting VSMC proliferation and migration, thereby exacerbating neointimal hyperplasia. • MiR-183-5p reduces BECN1 levels by targeting the 3′-untranslated region of BECN1 , inhibiting VSMC autophagy, thus exacerbating neointimal hyperplasia. • Hsa_circ_0001402 acts as a sponge for miR-183-5p. Introduction Vascular neointimal hyperplasia, a pathological process observed in cardiovascular diseases such as atherosclerosis and pulmonary hypertension, involves the abundant presence of vascular smooth muscle cells (VSMCs). The proliferation, migration, and autophagy of VSMCs are associated with the development of neointimal lesions. Circular RNAs (circRNAs) play a critical role in regulating VSMC proliferation and migration, thereby participating in neointimal hyperplasia. However, the regulatory role of circRNAs in VSMC autophagy remains unclear. Objectives We aimed to identify circRNAs that are involved in VSMC autophagy-mediated neointimal hyperplasia, as well as elucidate the underlying mechanisms. Methods Dual-luciferase reporter gene assay was performed to validate two competing endogenous RNA axes, hsa_circ_0001402 /miR-183-5p/FKBP prolyl isomerase like ( FKBPL ) and hsa_circ_0001402 /miR-183-5p/beclin 1 ( BECN1 ). Cell proliferation and migration analyses were employed to investigate the effect of hsa_circ_0001402 , miR-183-5p, or FKBPL on VSMC proliferation and migration. Cell autophagy analysis was conducted to reveal the role of hsa_circ_0001402 or miR-183-5p on VSMC autophagy. The role of hsa_circ_0001402 or miR-183-5p on neointimal hyperplasia was evaluated using a mouse model of common carotid artery ligation. Results Hsa_circ_0001402 acted as a sponge for miR-183-5p, leading to the suppression of miR-183-5p expression. Through direct interaction with the coding sequence (CDS) of FKBPL , miR-183-5p promoted VSMC proliferation and migration by decreasing FKBPL levels. Besides, miR-183-5p reduced BECN1 levels by targeting the 3′-untranslated region (UTR) of BECN1 , thus inhibiting VSMC autophagy. By acting as a miR-183-5p sponge, overexpression of hsa_circ_0001402 increased FKBPL levels to inhibit VSMC proliferation and migration, while simultaneously elevating BECN1 levels to activate VSMC autophagy, thereby alleviating neointimal hyperplasia. Conclusion Hsa_circ_0001402 , acting as a miR-183-5p sponge, increases FKBPL levels to inhibit VSMC proliferation and migration, while enhancing BECN1 levels to activate VSMC autophagy, thus alleviating neointimal hyperplasia. The hsa_circ_0001402 /miR-183-5p/ FKBPL axis and hsa_circ_0001402 /miR-183-5p/ BECN1 axis may offer potential therapeutic targets for neointimal hyperplasia. Graphical abstract Download : Download high-res image (112KB) Download : Download full-size image

Abstract 496: Inhibition Of Tirna-gly-gcc Ameliorates Neointimal Formation Via Cbx3-mediated Vascular Smooth Muscle Cells Phenotypic Switching

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

Transfer RNA-derived small RNA tRF-Glu-CTC attenuates neointimal formation via inhibition of fibromodulin

Inhibition of Polycomb Repressor Complex 2 Ameliorates Neointimal Hyperplasia by Suppressing Trimethylation of H3K27 in Vascular Smooth Muscle Cells.

A Novel tRNA-Derived Fragment, tRF<SUP>GlnCTG</SUP>, Regulates Angiogenesis by Targeting Antxr1 mRNA

Circdiaph3 Regulates Rat Vascular Smooth Muscle Cell Differentiation, Proliferation, and Migration

Nonratt000538.2 Promotes Vascular Smooth Muscle Cell Phenotypic Switch and In-Stent Restenosis

Activation of CD137 signaling promotes neointimal formation by attenuating TET2 and transferrring from endothelial cell-derived exosomes to vascular smooth muscle cells

Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia

Long Non-Coding RNAs Might Regulate Phenotypic Switch of Vascular Smooth Muscle Cells Acting as ceRNA: Implications for In-Stent Restenosis

Abstract 13125: The Role of FXR1 and Cellular Senescence in Vascular Pathology

C1q/TNF‐related protein 4 mediates proliferation and migration of vascular smooth muscle cells during vascular remodelling

Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation

Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation

SNHG18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia

Abstract 237: the Inhibitory Effect on Vascular Smooth Muscle Cell Hyperplasia in Artificial Atherosclerotic Mouse Model Via Mir-155 Induced NoxA1 Down Regulation

TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation

Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy

CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation

Abstract 719: PFKFB3 Mediated Glycolysis in Vascular Smooth Muscle Cells is Essential for Arterial Neointima Formation

m6A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway